Lyell Immunopharma, Inc. (LYEL)

Last Closing Price: 8.69 (2025-06-20)

Asset Turnover (Annual)

Asset Turnover: The amount of sales or revenues generated per dollar of assets. The Asset Turnover ratio is an indicator of the efficiency with which a company is deploying its assets. Calculated as: Total Revenues / Total Assets

Lyell Immunopharma, Inc. (LYEL) had Asset Turnover of 0.00 for the most recently reported fiscal year, ending 2024-12-31.

Figures for fiscal year ending 2024-12-31
Income Statement Financials
$0.06M
$-342.99M
--
$0.06M
$358.82M
$-358.75M
$15.76M
$-342.99M
$-329.99M
$-342.99M
$-342.99M
$-342.99M
$-329.99M
$-358.75M
$-353.81M
13.07M
13.07M
$-26.20
$-26.20
Balance Sheet Financials
$379.59M
$48.20M
$111.27M
$490.86M
$53.79M
--
$54.25M
$108.03M
$382.82M
$382.82M
$382.82M
14.74M
Cash Flow Statement Financials
$-162.39M
$122.42M
$1.33M
$145.93M
$107.29M
$-38.64M
$33.14M
--
--
Fundamental Metrics & Ratios
7.06
--
--
--
--
100.00%
-588122.90%
-588122.90%
-580008.10%
-562285.30%
-562285.20%
$-194.20M
--
--
--
Asset Turnover
0.00
--
--
--
-89.60%
-89.60%
-69.88%
-89.60%
$25.97
$-14.85
$-12.42